Ixabepilone for the treatment of endometrial cancer.

about

The prognostic value of D-dimer levels in endometrial cancer patients treated with intensity-modulated radiation therapy.Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.

P2860

Q42049307-500796C6-55C5-48DA-81B6-E7268230E88B Q55309854-B56F6069-4473-4165-86E6-4A6DB7CEB6DB

P2860

Ixabepilone for the treatment of endometrial cancer.

Item

http://www.wikidata.org/entity/Q38763500

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ixabepilone for the treatment of endometrial cancer.

@en

type

Item

label

Ixabepilone for the treatment of endometrial cancer.

@en

prefLabel

Ixabepilone for the treatment of endometrial cancer.

@en

P1476

Ixabepilone for the treatment of endometrial cancer

@en

P2093

Francesca De Felice

http://www.w3.org/2001/XMLSchema#string

Giorgia Perniola

http://www.w3.org/2001/XMLSchema#string

Ilaria Piacenti

http://www.w3.org/2001/XMLSchema#string

Innocenza Palaia

http://www.w3.org/2001/XMLSchema#string

Ludovica Imperiale

http://www.w3.org/2001/XMLSchema#string

Ludovico Muzii

http://www.w3.org/2001/XMLSchema#string

Pierluigi Benedetti Panici

http://www.w3.org/2001/XMLSchema#string

Serena Boccia

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.

A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship.

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies

Efficacy and safety of ixabepilone, a novel epothilone analogue.

Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.

Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms.

P304

613-618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2016.1161755

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Violante Di Donato

Claudia Marchetti

Marco Monti

P577

2016-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26949829

http://www.w3.org/2001/XMLSchema#string

Ixabepilone for the treatment of endometrial cancer.

about

P2860

P2860

Ixabepilone for the treatment of endometrial cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698